Basic Information
- Primary DI
- D-T05G2J10010ANV6
- Basic UDI-DI Code
- B-T05G2J10010ANV6
- Reference
- BRLMV‐BT‐01
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd Annex 2 List B
- Status
- On The Market
- Manufacturer
- Tyson Bioresearch, Inc.
Additional Description
The LGLMV-BT-01 Blood Glucose Monitoring System is intended for use in the quantitatively measurement of glucose (sugar) in fresh venous and capillary whole blood. It is not intended for neonatal testing. The BRLMV-BT-01 Blood Glucose Test Strips are for testing outside the body (in vitro diagnostic use). The LGLMV-BT-01 Blood Glucose Monitoring System is intended for use at home (Over the Counter [OTC]) by persons with diabetes, or in clinical setting by healthcare professionals as an aid in monitoring the effectiveness of diabetes control. It is not intended for the diagnosis of or screening for diabetes mellitus.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0101060101 | GLUCOSE TEST STRIPS |
Certificates
| Type | Number | Notified Body | Status |
|---|---|---|---|
| IVDD Annex IV (excluding sections 4, 6) | C-02-1073-797-22 | Eurofins Electric & Electronics Finland Oy | Expired |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).